NCT01712126View on ClinicalTrials.gov

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

Irbesartan and Hydrochlorothiazide

DRUG

Avalide

Trial Locations (1)

78217

Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research), San Antonio

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01712126 - Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter